Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 3, 2000, Pages 281-289

  Fell, J M E ^a,f   Paintin, M ^b   Arnaud Battandieri, F ^b   Beattie, R M ^c   Hollis, A ^d   Kitching, P ^e   Donnet Hughes, A ^b   MacDonald, T T ^d   Walker Smith, J A ^e  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c PETERBOROUGH DISTRICT HOSPITAL   (United Kingdom)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^e ROYAL FREE HOSPITAL   (United Kingdom)

^f IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESALAZINE; MESSENGER RNA; PREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; ENTERIC FEEDING; ENTERITIS; FEMALE; HISTOLOGY; HUMAN; ILEUM; MALE; PRIORITY JOURNAL; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; STOMACH BIOPSY;

ADOLESCENT; CHILD; COLON; COLONOSCOPY; CROHN DISEASE; CYTOKINES; ENTERAL NUTRITION; FEMALE; FOOD, FORMULATED; HUMANS; ILEUM; INTESTINAL MUCOSA; MALE; RECURRENCE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034016066     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00707.x     Document Type: Article

References (28)

1. 1 Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of Crohn's disease. Gastroenterology 1995; 108: 1056-67.
2. 2 Fernandez-Banares F, Cabre E, Esteve-Comas M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomised controlled trials. J Parenter Enter Nutr 1995; 19: 356-64.
3. 3 Messori A, Trallori G, D'Albasio M, Milla M, Vannozzi G, Pacini F. Defined-formula diets versus steroids in the treatment of active Crohn's disease. Scand J Gastroenterol 1996; 31: 267-72.
4. 4 Sanderson IR, Udeen S, Davies PSW, Savage MO, Walker-Smith JA. Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child 1987; 62: 123-7.
5. 5 Thomas AG, Taylor F, Miller V. Dietary intake and nutritional treatment in childhood Crohn's disease. J Paediatr Gastroenterol Nutr 1993; 17: 75-81.
6. 6 Azcue M, Rashid M, Griffiths A, Pencharaz PB. Energy expenditure and body composition with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut 1997; 41: 203-8.
7. 7 Gorard DA, Hunt JB, Payne-James JJ, et al. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut 1993; 34: 1198-202.
8. 8 Beattie RM, Schiffrin EJ, Donnet-Hughes A, et al. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther 1994; 8: 609-15.
9. 9 Breese EJ, Michie CA, Nicholls SW, et al. Tumor necrosis factor alpha producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994; 106: 1455-66.
10. 10 Breese EJ, Michie CA, Nicholls SW, et al. The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease. Aliment Pharmacol Ther 1995; 9: 547-52.
11. 11 Ferguson A, Glen M, Ghosh S. Crohn's disease: nutrition and nutritional therapy. Balliere's Clin Gastroenterol 1998; 12: 93-114.
12. 12 Hyams JS, Mandel F, Ferry GD, et al. Relationship of common laboratory parameters to the activity of Crohn's disease in children. J Paed Gastroenterol Nutr 1992; 14: 216-22.
13. 13 Freeman JV, Cole TJ, Chinn S, Jones PRM, White EM,Preece MA. Cross-sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 1995; 73: 17-24.
14. 14 Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for the UK, 1990. Arch Dis Child 1995; 73: 25-9.
15. 15 Williams CB, Nicholls SW. Endoscopic features of inflammatory bowel disease in children. Balliere's Clin Gastroenterol 1994; 8: 121-32.
16. 16 McDonald SAC, van Palmen HJHJ, Rees EP, MacDonald TT. Characterisation of the mucosal cell-mediated immune response in IL-2 knockout mice and the onset of colitis. Immunol 1997; 91: 73-80.
17. 17 Jung HC, Eckmann L, Yang SK, et al. A distinct array of pro inflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995; 95: 55-65.
18. 18 Seidman EG, Griffiths AM, Jones A, Issenman R. The Canadian paediatric Crohn's disease study group. Semi-elemental diet versus prednisolone in the treatment of active Crohn's disease in children and adolescents. Gastroenterology 1993; 104: A778(Abstract).
19. 19 Ruuska T, Savilahti E, Maki M, Ormala T, Visakorpi JK. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children. J Paediatr Gastroenterol Nutr 1994; 19: 175-80.
20. 20 Belli D, Seidman EG, Bouthillier L, et al. Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology 1988; 94: 603-10.
21. 21 Seidman E, Jones A, Issenman R, Griffiths A. Relapse prevention/growth enhancement in pediatric Crohn's disease: multicenter randomised controlled trial of intermittent enteral nutrition versus alternative day Prednisolone. J Pediatr Gastroenterol Nutr 1996; 23: 344(Abstract).
22. 22 Wilschanski M, Sherman P, Pencharz P, Davis L, Corey M, Griffiths A. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 1996; 38: 543-8.
23. 23 Gonzalez-Huix F, Leon R, Fernandez-Banares F, et al. Polymeric enteral diets as primary treatment of active Crohn's disease: prospective steroid controlled trial. Gut 1993; 34: 778-82.
24. 24 Michie HR, Spriggs DR, Manogue KR, et al. Tumour necrosis factor and endotoxin induce similar metabolic responses in human beings. Surg 1988; 104: 280.
25. 25 Fuss IJ, Neurath M, Boirivant M, et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in imflammatory bowel disease. J Immunol 1996; 157: 1261-70.
26. 26 Strober W, Kelsall B, Fuss I, Marth T, Ludviksson Bjorn Ehrhardt R, Neurath M. Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation. Immunol Today 1997; 18: 61-4.
27. 27 Podolsky DK. Inflammatory bowel disease (first of two parts). N Eng J Med 1991; 325: 928-37.
28. 28 Raouf AH, Hildrey V, Daniel J, et al. Enteral feeding as sole treatment for Crohn's disease: controlled trial of protein v aminoacid based feed and a case study of dietary challenge. Gut 1991; 32: 702-7.